Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double‐blind placebo‐controlled study

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-4527|3|2|45-55

ISSN： 2050-4527

Source： Immunity, Inflammation And Disease, Vol.3, Iss.2, 2015-06, pp. : 45-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study

By Yamamoto Hideyuki   Yamada Takechiyo   Kubo Seita   Osawa Yoko   Kimura Yuichi   Oh Myonmi   Susuki Dai   Takabayashi Tetsuji   Okamoto Masayuki   Fujieda Shigeharu  

Allergy and Asthma Proceedings, Vol. 31, Iss. 4, 2010-07 ,pp. : 296-303

OceanSide Publications, Inc

Access to resources Recommend Favorite

A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients

By Gossmann J.   Mondorf U.   Dietz A.   Kramer W.   Kachel H.-G.   Geiger H.   Scheuermann E.-H.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1767-1770

Elsevier

Access to resources Recommend Favorite

Nebulized dehydroepiandrosterone-3-sulfate improves asthma control in the moderate-to-severe asthma results of a 6-week, randomized, double-blind, placebo-controlled study

By Wenzel Sally E.   Robinson Cynthia B.   Leonard Joanne M.   Panettieri Reynold A.  

Allergy and Asthma Proceedings, Vol. 31, Iss. 6, 2010-11 ,pp. : 461-471

OceanSide Publications, Inc

Access to resources Recommend Favorite

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma

By Kishiyama J.L.   Valacer D.   Cunningham-Rundles C.   Sperber K.   Richmond G.W.   Abramson S.   Glovsky M.   Stiehm R.   Stocks J.   Rosenberg L.   Shames R.S.   Corn B.   Shearer W.T.   Bacot B.   DiMaio M.   Tonetta S.   Adelman D.C.  

Clinical Immunology, Vol. 91, Iss. 2, 1999-05 ,pp. : 126-133

Academic Press

Access to resources Recommend Favorite

Simvastatin effect on NK cells activity in vivo: a double-blind randomized, placebo-controlled study

By Santos A.F.   Keitel E.   Bittar A.E.   Neumann J.   Fonseca N.   Sporleder H.   Canabarro R.   Kroth L.   Saitovitch D.   Garcia V.D.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2874-2875

Elsevier

Access to resources Recommend Favorite